Dexamethasone associated with hydroxychloroquine vs. hydroxychloroquine alone for the early treatment of severe ARDS caused by COVID-19 : a randomized controlled trial : Dexamethasone associated with hydroxychloroquine vs. hydroxychloroquine alone for the early treatment of severe ARDS caused by COVID-19 : a randomized controlled trial - DHYSCO

Medienart:

Klinische Studie

Erscheinungsjahr:

2020

Erschienen:

2020

Enthalten in:

WHO International Clinical Trials Registry Platform - (2020) vom: 18. Aug. Zur Gesamtaufnahme - year:2020

Sprache:

Englisch

Links:

Volltext [kostenfrei]

Themen:

610
Medical Condition: Acute Respiratory Distress Syndrome (ARDS) caused by SARS-Cov-2 infection;Therapeutic area: Diseases [C] - Virus Diseases [C02]
Phase: Phase 3
Recruitment Status: Not yet recruiting
Study Type: Interventional

Anmerkungen:

WHO International Clinical Trials Registry Platform (https://www.who.int/ictrp/en/), First posted: 02-04-2020, Last updated: 2022-11-24

ICTRP ID:

EUCTR2020-001333-13-FR
20-37815010

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

WHO007187440